(DANRE) adra2db Blocking Peptide (C-Term)
€363.00
In stock
SKU
AC-BP21170a
Background:
Alpha-2 adrenergic receptors mediate the catecholamine- induced inhibition of adenylate cyclase through the action of G proteins. The order of potency for this receptor is dexmedetomidine > norepinephrine = epinephrine > oxymetazoline.
Other Names:
Alpha-2Db adrenergic receptor, Alpha-2Db adrenoceptor, Alpha(2Db)AR, Alpha-2Db adrenoreceptor, adra2db
Target/Specificity:
The synthetic peptide sequence is selected from aa 323-336 of HUMAN adra2db
Gene Name: adra2db
Gene ID: 266755
Primary Accession: Q8JG69
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Alpha-2 adrenergic receptors mediate the catecholamine- induced inhibition of adenylate cyclase through the action of G proteins. The order of potency for this receptor is dexmedetomidine > norepinephrine = epinephrine > oxymetazoline.
Other Names:
Alpha-2Db adrenergic receptor, Alpha-2Db adrenoceptor, Alpha(2Db)AR, Alpha-2Db adrenoreceptor, adra2db
Target/Specificity:
The synthetic peptide sequence is selected from aa 323-336 of HUMAN adra2db
Gene Name: adra2db
Gene ID: 266755
Primary Accession: Q8JG69
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review